Food and Drug Administration

Pharmacy Compounding Advisory Committee

October 14, 15, 16, 1998

Slides

_____________________________________________________________

TOBI Tobramycin Solution for Inhalation, William H. Pitlick, Ph.D. (PDF)

FDA Intrductory Remarks, Jane A. Axelrad, Associate Director for Policy, Center for Drug Evaluation and Research (PDF)

Bulk Drug Substances, Capt. Robert Tonelli, M.S., R.Ph. (PDF)

Withdrawn or Removed Drug Products, Capt. George R. Scott, M.S., R.Ph. (PDF)